- Home
- OSPN vs MGTX Comparison
OSPN vs MGTX Comparison
Compare OSPN & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OSPN
- MGTX
- Stock Information
- Founded
- OSPN 1991
- MGTX 2015
- Country
- OSPN United States
- MGTX United States
- Employees
- OSPN N/A
- MGTX N/A
- Industry
- OSPN EDP Services
- MGTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- OSPN Technology
- MGTX Health Care
- Exchange
- OSPN Nasdaq
- MGTX Nasdaq
- Market Cap
- OSPN 597.9M
- MGTX 670.2M
- IPO Year
- OSPN 1998
- MGTX N/A
- Fundamental
- Price
- OSPN $15.79
- MGTX $7.33
- Analyst Decision
- OSPN Strong Buy
- MGTX Strong Buy
- Analyst Count
- OSPN 3
- MGTX 2
- Target Price
- OSPN $19.67
- MGTX $24.00
- AVG Volume (30 Days)
- OSPN 447.2K
- MGTX 276.6K
- Earning Date
- OSPN 10-29-2025
- MGTX 11-12-2025
- Dividend Yield
- OSPN 3.07%
- MGTX N/A
- EPS Growth
- OSPN 265.73
- MGTX N/A
- EPS
- OSPN 1.53
- MGTX N/A
- Revenue
- OSPN $240,621,000.00
- MGTX $37,917,000.00
- Revenue This Year
- OSPN $4.23
- MGTX $145.67
- Revenue Next Year
- OSPN $5.58
- MGTX $167.61
- P/E Ratio
- OSPN $10.22
- MGTX N/A
- Revenue Growth
- OSPN N/A
- MGTX 366.84
- 52 Week Low
- OSPN $12.51
- MGTX $3.94
- 52 Week High
- OSPN $20.37
- MGTX $8.98
- Technical
- Relative Strength Index (RSI)
- OSPN 63.37
- MGTX 42.80
- Support Level
- OSPN $15.27
- MGTX $7.21
- Resistance Level
- OSPN $15.79
- MGTX $7.91
- Average True Range (ATR)
- OSPN 0.35
- MGTX 0.35
- MACD
- OSPN 0.09
- MGTX -0.02
- Stochastic Oscillator
- OSPN 81.65
- MGTX 19.89
About OSPN OneSpan Inc.
OneSpan Inc is a provider of information technology security solutions for banking and financial services and application security markets. Its solutions secure and manage access to digital assets and protect online transactions, via mobile devices and in-person. Authentication and anti-fraud solutions are the organization's primary product offerings and include multifactor authentication and virtual private network access capabilities. The company derives revenues from hardware and license fees, maintenance and support fees, and subscription fees. A large majority of the firm's revenue is generated in Europe, the Middle East, and Africa, and the rest in the United States and Asia-Pacific region.
About MGTX MeiraGTx Holdings plc
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.